Cohance Lifesciences Ltd (COHANCE) — Voting Results | 17 September 2026

17 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

All three AGM resolutions passed with requisite majority

🔄 What Changed

Adoption of standalone and consolidated financial statements; reappointment of Ms. Shweta Jalan as director

💡 Investor Takeaway

Shareholders approved key financial reports and director reappointment, confirming governance continuity.

Cohance Lifesciences held its 8th Annual General Meeting on 17 September 2026 via video conference, approving standalone and consolidated financial statements and reappointing Ms. Shweta Jalan as director. The meeting concluded at 5:21 p.m. IST after e-voting concluded, with all resolutions passed by requisite majority. Shareholder turnout included 50 attendees from 97,424 eligible holders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — COHANCE ✨ Ask AI About This

About Cohance Lifesciences Ltd (COHANCE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹17,473.75 CrP/E: 298.5ROE: 2.7%ROCE: 3.3%

View full COHANCE stock details →

📡 Get AI alerts when COHANCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track COHANCE — Free

💡 Ask AI about this filing

"What were the exact vote counts for each resolution?""How does this reappointment affect board composition?""What is the company's dividend outlook for FY2026?"

Ask AI Free →

📊 More COHANCE filings

Announcement — 28 September 2026Cohance Lifesciences Ltd announced that its trading window closes on 1 October 2026 for insiders and...
Announcement — 21 September 2026Cohance Lifesciences announced that the USFDA inspected its API facility in Andhra Pradesh from Sept...
🟡 Board Meeting — 18 September 2026Cohance Lifesciences invested USD 10 million in newly issued Compulsorily Convertible Preferred Stoc...
🔴 Announcement — 5 September 2026Cohance Lifesciences announced that the USFDA completed an inspection of its formulation plant in Sh...
🟡 Board Meeting — 3 September 2026Cohance Lifesciences announced a strategic reorganisation involving two key transactions: acquiring ...

See all COHANCE filings →

🔥 Also filed on 17 September 2026

EICHERMOTEicher Motors LtdAnnouncement SGMARTSG Mart LtdAnnouncement NEOGENNeogen Chemicals LtdCorporate Action BRAHMINFRABrahmaputra Infrastructure LtdAnnouncement PVPPVP Ventures LtdCorporate Action SONACOMSSona BLW Precision Forgings LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when COHANCE files new disclosures

Track COHANCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.